Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients
Alice Courties, Jérémy Boussier, Jérôme Hadjadj, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives
Marianne Lauwers, Man Ting Au, Shuofeng Yuan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 720-720
Open Access | Times Cited: 50
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases
Ana Sofía Vallés, Francisco J. Barrantes
Cells (2023) Vol. 12, Iss. 16, pp. 2051-2051
Open Access | Times Cited: 19
Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research
Marta Kopańska, Marta Batoryna, Paulina Bartman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 672-672
Open Access | Times Cited: 28
Cholinergic dysfunction in COVID-19: frantic search and hoping for the best
Eman Hassan Nadwa, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 3, pp. 453-468
Open Access | Times Cited: 28
SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production
Naomi Oka, Kazuya Shimada, Azusa Ishii, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106954-106954
Open Access | Times Cited: 14
Translational implications of CHRFAM7A, an elusive human-restricted fusion gene
Ivanna Ihnatovych, Ruth-Ann Saddler, Norbert Süle, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 1020-1032
Open Access | Times Cited: 5
The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders
Simona Di Lascio, Diego Fornasari, Roberta Benfante
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3463-3463
Open Access | Times Cited: 22
Toxin-like Peptides from the Bacterial Cultures Derived from Gut Microbiome Infected by SARS-CoV-2—New Data for a Possible Role in the Long COVID Pattern
Carlo Brogna, Simone Cristoni, Barbara Brogna, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 87-87
Open Access | Times Cited: 19
Prevalence and clinical relevance of viraemia in viral respiratory tract infections: a systematic review
Karl Hagman, Tamara Postigo, David Diez-Castro, et al.
The Lancet Microbe (2024), pp. 100967-100967
Open Access | Times Cited: 4
Citicoline and COVID-19: vis-à-vis conjectured
Hayder M. Al‐kuraishy, Ali K. Albuhadily, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 12, pp. 1463-1475
Open Access | Times Cited: 15
Activités des cholinestérases et encéphalopathie associée au sepsis dans le sepsis viral versus non viral
C. Richard Neu, Ricardo Esper Treml, Philipp Baumbach, et al.
Canadian Journal of Anesthesia/Journal canadien d anesthésie (2024) Vol. 71, Iss. 3, pp. 378-389
Open Access | Times Cited: 2
Deciphering the molecular pathways underlying dopaminergic neuronal damage in Parkinson's disease associated with SARS-CoV-2 infection
Qiuhan Xu, Sisi Jiang, Ruiqing Kang, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108200-108200
Closed Access | Times Cited: 2
Transcriptional Profiles Analysis of COVID-19 and Malaria Patients Reveals Potential Biomarkers in Children
Nzungize Lambert, Jonas A. Kengne-Ouafo, Wesonga Makokha Rissy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Understanding the Pivotal Role of the Vagus Nerve in Health from Pandemics
Claire-Marie Rangon, Adam Niezgoda
Bioengineering (2022) Vol. 9, Iss. 8, pp. 352-352
Open Access | Times Cited: 10
The emergence of the uniquely human α7 nicotinic acetylcholine receptor gene and its roles in inflammation
Wanling Peng, Liang Mao, Xitong Dang
Gene (2022) Vol. 842, pp. 146777-146777
Closed Access | Times Cited: 10
Polymorphisms in alpha 7 nicotinic acetylcholine receptor gene, CHRNA7 , and its partially duplicated gene, CHRFAM7A , associate with increased inflammatory response in human peripheral mononuclear cells
Bagmi Pattanaik, Maria Hammarlund, Filip Mjörnstedt, et al.
The FASEB Journal (2022) Vol. 36, Iss. 5
Open Access | Times Cited: 8
An experimental test of the nicotinic hypothesis of COVID-19
Nicole E. Godellas, Gisela D. Cymes, Claudio Grosman
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 44
Open Access | Times Cited: 8
Nicotine exposure decreases likelihood of SARS-CoV-2 RNA expression and neuropathology in the hACE2 mouse brain but not moribundity
Ayland C. Letsinger, James M. Ward, Rick D. Fannin, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Unanswered questions in the regulation and function of the duplicated α7 nicotinic receptor gene CHRFAM7A
Sherry Leonard, Roberta Benfante
Pharmacological Research (2023) Vol. 192, pp. 106783-106783
Open Access | Times Cited: 4
Regulation of Inflammation by IRAK-M Pathway Can Be Associated with nAchRalpha7 Activation and COVID-19
Alessanda S. Rieder, Angela T. S. Wyse
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 581-592
Closed Access | Times Cited: 4
Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study
Florian Espeter, David Künne, Lena Garczarek, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2150-2150
Open Access | Times Cited: 7
CHRFAM7A diversifies human immune adaption through Ca2+ signalling and actin cytoskeleton reorganization
Kinga Szigeti, Ivanna Ihnatovych, Emily Notari, et al.
EBioMedicine (2024) Vol. 103, pp. 105093-105093
Open Access | Times Cited: 1
Inflammatory reflex disruption in COVID‐19
Khalil Hajiasgharzadeh, Mahdi Jafarlou, Behzad Mansoori, et al.
Clinical and Experimental Neuroimmunology (2022) Vol. 13, Iss. 4, pp. 295-301
Open Access | Times Cited: 5
The Impact of Smoking Status and Smoking-Related Comorbidities on Coronavirus Disease 2019 Patient Outcomes: A Causal Mediation Analysis
Claire L. Le Guen, Kelsey C Muir, Melanie Simons, et al.
Nicotine & Tobacco Research (2022) Vol. 25, Iss. 2, pp. 331-338
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top